Found: 60
Select item for more details and to access through your institution.
Gender Representation of Health Care Professionals in Large Language Model–Generated Stories.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 9, p. e2434997, doi. 10.1001/jamanetworkopen.2024.34997
- By:
- Publication type:
- Article
Proteomic profiling of paired human liver homogenate and tissue derived extracellular vesicles.
- Published in:
- Proteomics, 2024, v. 24, n. 11, p. 1, doi. 10.1002/pmic.202300025
- By:
- Publication type:
- Article
Artificial intelligence chatbots will revolutionize how cancer patients access information: ChatGPT represents a paradigm-shift.
- Published in:
- JNCI Cancer Spectrum, 2023, v. 7, n. 2, p. 1, doi. 10.1093/jncics/pkad010
- By:
- Publication type:
- Article
C-reactive protein provides superior prognostic accuracy than the IMDC risk model in renal cell carcinoma treated with Atezolizumab/Bevacizumab.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.918993
- By:
- Publication type:
- Article
Insights into Melanoma Clinical Practice: A Perspective for Future Research.
- Published in:
- Cancers, 2023, v. 15, n. 18, p. 4631, doi. 10.3390/cancers15184631
- By:
- Publication type:
- Article
Prediction of Prostate Cancer Biochemical and Clinical Recurrence Is Improved by IHC-Assisted Grading Using Appl1, Sortilin and Syndecan-1.
- Published in:
- Cancers, 2023, v. 15, n. 12, p. 3215, doi. 10.3390/cancers15123215
- By:
- Publication type:
- Article
Reply to Auclin et al. Comment on "Hopkins et al. Value of the Lung Immune Prognostic Index in Patients with Non-Small Cell Lung Cancer Initiating First-Line Atezolizumab Combination Therapy: Subgroup Analysis of the IMPOWER150 Trial. Cancers 2021, 13 , 1176"
- Published in:
- Cancers, 2021, v. 13, n. 15, p. 3763, doi. 10.3390/cancers13153763
- By:
- Publication type:
- Article
Machine Learning for Prediction of Survival Outcomes with Immune-Checkpoint Inhibitors in Urothelial Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 9, p. 2001, doi. 10.3390/cancers13092001
- By:
- Publication type:
- Article
Value of the Lung Immune Prognostic Index in Patients with Non-Small Cell Lung Cancer Initiating First-Line Atezolizumab Combination Therapy: Subgroup Analysis of the IMPOWER150 Trial.
- Published in:
- Cancers, 2021, v. 13, n. 5, p. 1176, doi. 10.3390/cancers13051176
- By:
- Publication type:
- Article
Risk Factors for Severe Diarrhea with an Afatinib Treatment of Non-Small Cell Lung Cancer: A Pooled Analysis of Clinical Trials.
- Published in:
- Cancers, 2018, v. 10, n. 10, p. 384, doi. 10.3390/cancers10100384
- By:
- Publication type:
- Article
Use of Physiologically Based Pharmacokinetic Modeling to Identify Physiological and Molecular Characteristics Driving Variability in Axitinib Exposure: A Fresh Approach to Precision Dosing in Oncology.
- Published in:
- Journal of Clinical Pharmacology, 2019, v. 59, n. 6, p. 872, doi. 10.1002/jcph.1377
- By:
- Publication type:
- Article
Low Risk of Hyperprogression with First-Line Chemoimmunotherapy for Advanced Non-Small Cell Lung Cancer: Pooled Analysis of 7 Clinical Trials.
- Published in:
- Oncologist, 2023, v. 28, n. 4, p. e205, doi. 10.1093/oncolo/oyad043
- By:
- Publication type:
- Article
Patient‐Reported Outcomes Predict Progression‐Free Survival of Patients with Advanced Breast Cancer Treated with Abemaciclib.
- Published in:
- Oncologist, 2021, v. 26, n. 7, p. 562, doi. 10.1002/onco.13806
- By:
- Publication type:
- Article
Regarding the Article by Rugo et al.
- Published in:
- Oncologist, 2021, v. 26, n. 7, p. e1285, doi. 10.1002/onco.13781
- By:
- Publication type:
- Article
Potential of Large Language Models as Tools Against Medical Disinformation—Reply.
- Published in:
- JAMA Internal Medicine, 2024, v. 184, n. 4, p. 450, doi. 10.1001/jamainternmed.2024.0023
- By:
- Publication type:
- Article
Health Disinformation Use Case Highlighting the Urgent Need for Artificial Intelligence Vigilance: Weapons of Mass Disinformation.
- Published in:
- JAMA Internal Medicine, 2024, v. 184, n. 1, p. 92, doi. 10.1001/jamainternmed.2023.5947
- By:
- Publication type:
- Article
Evidence-Based Guidelines for Drug Interaction Studies: Model-Informed Time Course of Intestinal and Hepatic CYP3A4 Inhibition by Clarithromycin.
- Published in:
- AAPS Journal, 2021, v. 23, n. 5, p. 1, doi. 10.1208/s12248-021-00632-7
- By:
- Publication type:
- Article
Application of Model Informed Precision Dosing to Address the Impact of Pregnancy Stage and CYP2D6 Phenotype on Foetal Morphine Exposure.
- Published in:
- AAPS Journal, 2021, v. 23, n. 1, p. 1, doi. 10.1208/s12248-020-00541-1
- By:
- Publication type:
- Article
Risk factors for severe rash with use of vemurafenib alone or in combination with cobimetinib for advanced melanoma: pooled analysis of clinical trials.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Risk factors for MEK-associated retinopathy in patients with advanced melanoma treated with combination BRAF and MEK inhibitor therapy.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920944359
- By:
- Publication type:
- Article
Prognostic Associations of Concomitant Antibiotic Use in Patients with Advanced NSCLC Treated with Atezolizumab: Sensitivity Analysis of a Pooled Investigation of Five Randomised Control Trials.
- Published in:
- Biomedicines, 2023, v. 11, n. 2, p. 528, doi. 10.3390/biomedicines11020528
- By:
- Publication type:
- Article
Selective Isolation of Liver-Derived Extracellular Vesicles Redefines Performance of miRNA Biomarkers for Non-Alcoholic Fatty Liver Disease.
- Published in:
- Biomedicines, 2022, v. 10, n. 1, p. 195, doi. 10.3390/biomedicines10010195
- By:
- Publication type:
- Article
Commentary: Association Between Antihypertensive Medication Use and Breast Cancer: A Systematic Review and Meta-Analysis.
- Published in:
- Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.732622
- By:
- Publication type:
- Article
Efficacy of first-line atezolizumab combination therapy in patients with non-small cell lung cancer receiving proton pump inhibitors: post hoc analysis of IMpower150.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Predicting response and toxicity to immune checkpoint inhibitors using routinely available blood and clinical markers.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A 10-year update to the principles for clinical trial data sharing by pharmaceutical companies: perspectives based on a decade of literature and policies.
- Published in:
- BMC Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12916-023-03113-0
- By:
- Publication type:
- Article
Effect of early adverse events resulting in sorafenib dose adjustments on survival outcomes of advanced hepatocellular carcinoma patients.
- Published in:
- International Journal of Clinical Oncology, 2020, v. 25, n. 9, p. 1672, doi. 10.1007/s10147-020-01698-7
- By:
- Publication type:
- Article
A lack of association between BMI and chemoimmunotherapy efficacy in advanced non-small cell lung cancer: Secondary analysis of the IMpower150 and IMpower130 clinical trials.
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12132-w
- By:
- Publication type:
- Article
A clinical scoring tool validated with machine learning for predicting severe hand–foot syndrome from sorafenib in hepatocellular carcinoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2022, v. 89, n. 4, p. 479, doi. 10.1007/s00280-022-04411-9
- By:
- Publication type:
- Article
Relationship between vemurafenib plasma concentrations and survival outcomes in patients with advanced melanoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Genetic polymorphism of CYP1A2 but not total or free teriflunomide concentrations is associated with leflunomide cessation in rheumatoid arthritis.
- Published in:
- British Journal of Clinical Pharmacology, 2016, v. 81, n. 1, p. 113, doi. 10.1111/bcp.12760
- By:
- Publication type:
- Article
Prognostic model of survival outcomes in non-small cell lung cancer patients initiated on afatinib: pooled analysis of clinical trial data.
- Published in:
- Cancer Biology & Medicine, 2019, v. 16, n. 2, p. 341, doi. 10.20892/j.issn.2095-3941.2018.0474
- By:
- Publication type:
- Article
Validation of a 3-h Sampling Interval to Assess Variability in Cytochrome P450 3A Phenotype and the Impact of Induction and Mechanism-Based Inhibition Using Midazolam as a Probe Substrate.
- Published in:
- Frontiers in Pharmacology, 2019, p. 1, doi. 10.3389/fphar.2019.01120
- By:
- Publication type:
- Article
Predictors of Long-Term Disease Control and Survival for HER2-Positive Advanced Breast Cancer Patients Treated With Pertuzumab, Trastuzumab, and Docetaxel.
- Published in:
- Frontiers in Oncology, 2019, p. 1, doi. 10.3389/fonc.2019.00789
- By:
- Publication type:
- Article
Female reproductive status and exogenous sex hormone use in rheumatoid arthritis patients treated with tocilizumab and csDMARDs.
- Published in:
- Rheumatology, 2023, v. 62, n. 2, p. 583, doi. 10.1093/rheumatology/keac357
- By:
- Publication type:
- Article
The association of depression and anxiety with treatment outcomes in patients with rheumatoid arthritis – a pooled analysis of five randomised controlled trials.
- Published in:
- Therapeutic Advances in Musculoskeletal Disease, 2022, p. 1, doi. 10.1177/1759720X221111613
- By:
- Publication type:
- Article
Concomitant beta-blocker use is associated with a reduced rate of remission in patients with rheumatoid arthritis treated with disease-modifying anti-rheumatic drugs: a post hoc multicohort analysis.
- Published in:
- Therapeutic Advances in Musculoskeletal Disease, 2021, p. 1, doi. 10.1177/1759720X211009020
- By:
- Publication type:
- Article
Survival Outcomes of Nonsmall Cell Lung Cancer Patients Treated with Afatinib Who Are Affected by Early Adverse Events.
- Published in:
- Journal of Oncology, 2021, p. 1, doi. 10.1155/2021/2414897
- By:
- Publication type:
- Article
Stability Study of a Thalidomide Suspension.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Stability Study of a Thalidomide Suspension.
- Published in:
- Journal of Pharmacy Practice & Research, 2012, v. 42, n. 2, p. 115, doi. 10.1002/j.2055-2335.2012.tb00146.x
- By:
- Publication type:
- Article
Effect of early adverse events resulting in ado-trastuzumab emtansine dose adjustments on survival outcomes of HER2+ advanced breast cancer patients.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 178, n. 2, p. 473, doi. 10.1007/s10549-019-05393-8
- By:
- Publication type:
- Article
The obesity paradox in early and advanced HER2 positive breast cancer: pooled analysis of clinical trial data.
- Published in:
- NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-021-00241-9
- By:
- Publication type:
- Article
Time to deterioration of patient-reported outcomes as a surrogate of overall survival: a meta-analysis.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 12, p. 1475, doi. 10.1093/jnci/djad152
- By:
- Publication type:
- Article
RE: Smoking History as a Potential Predictor of Immune Checkpoint Inhibitor Efficacy in Metastatic Non-Small Cell Lung Cancer.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Effect of early adverse events on response and survival outcomes of advanced melanoma patients treated with vemurafenib or vemurafenib plus cobimetinib: A pooled analysis of clinical trial data.
- Published in:
- Pigment Cell & Melanoma Research, 2019, v. 32, n. 4, p. 576, doi. 10.1111/pcmr.12773
- By:
- Publication type:
- Article
Data sharing from pharmaceutical industry sponsored clinical studies: audit of data availability.
- Published in:
- 2018
- By:
- Publication type:
- letter
The effect of proton pump inhibitors on survival outcomes in advanced hepatocellular carcinoma treated with sorafenib.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2020, v. 146, n. 10, p. 2693, doi. 10.1007/s00432-020-03261-3
- By:
- Publication type:
- Article
Nuances to precision dosing strategies of targeted cancer medicines.
- Published in:
- Pharmacology Research & Perspectives, 2020, v. 8, n. 4, p. 1, doi. 10.1002/prp2.625
- By:
- Publication type:
- Article
Association between obesity and remission in rheumatoid arthritis patients treated with disease-modifying anti-rheumatic drugs.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-75673-7
- By:
- Publication type:
- Article
The Influence of Pre-Existing Beta-Blockers Use on Survival Outcomes in HER2 Positive Advanced Breast Cancer: Pooled Analysis of Clinical Trial Data.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. 1, doi. 10.3389/fonc.2020.01130
- By:
- Publication type:
- Article